FT3 - FREE TRIIODOTHYRONINE
Report
- Report Number
- 1823260-2015-04113
- Event Type
- Malfunction
- Date Received
- September 10, 2015
- Date of Event
- August 11, 2015
- Report Date
- September 10, 2015
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- CDP
- PMA / PMN Number
- K963127
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THIS EVENT OCCURRED IN (B)(6).
THE CUSTOMER QUESTIONED RESULTS FROM 1 PATIENT SAMPLE TESTED FOR THYROTROPIN (TSH), FREE THYROXINE (FT4) AND FREE TRIIODOTHYRONINE (FT3). THE CUSTOMER HAD COMPARED RESULTS FROM THEIR E 170 ANALYZER TO AN EXTERNAL LABORATORY WHERE A LUMIPULSE ANALYZER WAS USED. THE CUSTOMER PROVIDED THE SAMPLE FOR INVESTIGATION. OF THE DATA PROVIDED, ERRONEOUS FT4 AND FT3 RESULTS WERE IDENTIFIED BETWEEN THE CUSTOMER'S E 170 ANALYZER, A LUMIPULSE ANALYZER, AN E 170 ANALYZER USED AT THE INVESTIGATION SITE AND AN E411 ANALYZER USED AT THE INVESTIGATION SITE. IT IS NOT KNOWN IF ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THIS MEDWATCH WILL COVER FT3. REFER TO MEDWATCH WITH (B)(6) FOR INFORMATION ON THE FT4 ERRONEOUS RESULTS. NO ADVERSE EVENT WAS REPORTED. THE E 170 ANALYZER SERIAL NUMBER WAS (B)(4). THE E411 ANALYZER SERIAL NUMBER WAS (B)(4). THE FT3 REAGENT LOT NUMBER USED WITH THE E170 ANALYZER AT THE INVESTIGATION SITE WAS 185694 WITH AN EXPIRATION DATE OF 05/2016. THE FT3 REAGENT LOT NUMBER USED WITH THE E411 ANALYZER AT THE INVESTIGATION SITE WAS 183221 WITH AN EXPIRATION DATE OF 01/2016. THE SERIAL NUMBER FOR THE CUSTOMER'S E 170 ANALYZER WAS (B)(4). A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. THERE WAS NOT ENOUGH SAMPLE VOLUME LEFT TO COMPLETE THE INVESTIGATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 598943 | FT3 - FREE TRIIODOTHYRONINE | RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE | CDP | ROCHE DIAGNOSTICS | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |